Sonia Portillo, Author at Onco'Zine

1282 POSTS 0 COMMENTS

Sonia Portillo is an associate editor of ADC Review | Journal of Antibody-Drug Conjugates, an online, peer reviewed publication dedicated to following the developments of ADCs and other targeted therapies and a contributing editor to Onco'Zine. Portillo studies cancer treatment from a pharmacological perspective, specifically in the area of precision and personalized medicine.

Study Reveals Higher Risks of HPV-Related Cancers in HIV-Infected Hispanic Adults

Sonia Portillo - October 24, 2018

Executives from American Express and J.P. Morgan Join St. Baldrick’s Foundation...

Sonia Portillo - October 24, 2018

Phase Ib/II Data of Durvalumab Plus Danvatirsen Shows Promise in Head...

Sonia Portillo - October 22, 2018

Nivolumab + Low-dose Ipilimumab may be First Line Treatment in Some...

Sonia Portillo - October 22, 2018

Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals

Sonia Portillo - October 21, 2018

Dana-Farber to Investigate New Therapy for Brain Cancer

Sonia Portillo - October 21, 2018

Study of AXL Inhibitor DS-1205 in EGFR-Mutated Metastatic Non-Small Cell Lung...

Sonia Portillo - October 19, 2018

Featured image: Encouraging mother with breast cancer. 2018-2020 Fotolia/Adobe. used with permission.

Novel Statistical Method Estimates Time to Metastasis of Breast Cancer

Sonia Portillo - October 19, 2018

NanoValent Receives NIH SBIR Funding for Antibody-conjugated Nanoparticle Technology

Sonia Portillo - October 1, 2018

Study Confirms CT Screening for Nodule Volume Management Reduces Lung Cancer...

Sonia Portillo - September 26, 2018

12 3...129 Page 1 of 129

LATEST NEWS

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Editorial Team - March 13, 2023

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

Danielle Garcia - February 27, 2023

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Editorial Team - February 27, 2023

Finding a Cure for Nonalcoholic Fatty Liver Disease

Editorial Team - February 23, 2023

Why Do Politicians Weaponize Medicare? Because It Works!

Julie Rovner - February 21, 2023

Press Releases | Cancer

Unlocking the Power of Rick Simpson Oil: A Revolutionary Breakthrough... March 20, 2023
The power of Rick Simpson Oil (RSO) has been unlocked in an exciting new development. Used to treat a wide range of medical conditions and ailments, this oil is now more accessible than ever before.(PRWeb March 20, 2023)Read the full story at https://www.prweb.com/releases/unlocking_the_power_of_rick_simpson_oil_a_revolutionary_breakthrough_in_health_and_wellness/prweb19233768.htm
Deep Bio’s Novel Study Results Reaffirm Its Global Presence March 14, 2023
USCAP 2023 is Deep Bio’s sixth consecutive year of presenting research abstracts(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/03/prweb19209392.htm
Study Adds Support for Cxbladder Monitor Use in Cancer Surveillance March 14, 2023
Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) welcomes the release of new research supporting the clinical utility of the company’s genomic biomarker test Cxbladder Monitor in the...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/3/prweb19220555.htm

Sonia Portillo

Study Reveals Higher Risks of HPV-Related Cancers in HIV-Infected Hispanic Adults

Executives from American Express and J.P. Morgan Join St. Baldrick’s Foundation...

Phase Ib/II Data of Durvalumab Plus Danvatirsen Shows Promise in Head...

Nivolumab + Low-dose Ipilimumab may be First Line Treatment in Some...

Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals

Dana-Farber to Investigate New Therapy for Brain Cancer

Study of AXL Inhibitor DS-1205 in EGFR-Mutated Metastatic Non-Small Cell Lung...

Novel Statistical Method Estimates Time to Metastasis of Breast Cancer

NanoValent Receives NIH SBIR Funding for Antibody-conjugated Nanoparticle Technology

Study Confirms CT Screening for Nodule Volume Management Reduces Lung Cancer...

LATEST NEWS

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Finding a Cure for Nonalcoholic Fatty Liver Disease

Why Do Politicians Weaponize Medicare? Because It Works!

Pfizer Agrees to Acquire Seagen for US $ 43 Billion

Byondis Plans First-in-human Dose Escalation/Expansion Study With the SIRPα-directed BYON4228

FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...